Pyrazolone drugs and agranulocytosis
- PMID: 3463184
Item in Clipboard
Pyrazolone drugs and agranulocytosis
Agents Actions Suppl.
1986.
Abstract
Ever since mass consumption of chemically pure drugs started at the beginning of this century, cases of agranulocytosis have been reported in the literature. These were very soon seen as being causally related to drug use. The present paper discusses the clinical symptoms of the disease, the possibilities of its treatment, and the obvious connections between the use of pyrazolone drugs and the occurrence of agranulocytosis.
Similar articles
-
Agranulocytosis and pyrazolone analgesics.Lancet. 1984 Mar 31;1(8379):730. doi: 10.1016/s0140-6736(84)92237-2. Lancet. 1984. PMID: 6143055 No abstract available.
-
Agranulocytosis and pyrazolone.Lancet. 1984 Jun 30;1(8392):1471. doi: 10.1016/s0140-6736(84)91966-4. Lancet. 1984. PMID: 6145910 No abstract available.
-
Agranulocytosis and pyrazolone.Lancet. 1984 Feb 25;1(8374):451-2. doi: 10.1016/s0140-6736(84)91779-3. Lancet. 1984. PMID: 6142175 No abstract available.
-
Hypersensitivity to pyrazolones.Thorax. 2000 Oct;55 Suppl 2(Suppl 2):S72-4. doi: 10.1136/thorax.55.suppl_2.s72. Thorax. 2000. PMID: 10992566 Free PMC article. Review. No abstract available.
-
[Drugs and blood].Schweiz Rundsch Med Prax. 1985 Jan 15;74(3):40-5. Schweiz Rundsch Med Prax. 1985. PMID: 2857497 Review. German. No abstract available.